Coherus closes $55M Innovatus term loan, repays prior 8%+SOFR facility due 2029

Coherus Oncology, Inc.

Drew full $55M Tranche A on Aug 14, 2026; matures Aug 2031; rate 4.15% + greater of Prime or 6.75%.
Proceeds repaid prior senior secured facility (8.0% + 3-mo SOFR, due May 2029); remainder for working capital.
Interest-only for 36 months, extendable to 48 months upon revenue and market-cap milestones.
Optional tranches: $25M Term B (milestone-gated) and $20M Term C (lender discretion).
Prepayment fee 5% declining to 0% after year 3; final fee 4% (10% if DIP financing); facility fee 1.5%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.